Advertisement
Canada markets close in 5 hours 46 minutes
  • S&P/TSX

    21,966.09
    -45.63 (-0.21%)
     
  • S&P 500

    5,078.26
    +7.71 (+0.15%)
     
  • DOW

    38,476.34
    -27.35 (-0.07%)
     
  • CAD/USD

    0.7293
    -0.0027 (-0.37%)
     
  • CRUDE OIL

    82.98
    -0.38 (-0.46%)
     
  • Bitcoin CAD

    90,652.28
    -894.09 (-0.98%)
     
  • CMC Crypto 200

    1,423.97
    -0.13 (-0.01%)
     
  • GOLD FUTURES

    2,331.40
    -10.70 (-0.46%)
     
  • RUSSELL 2000

    2,003.42
    +0.78 (+0.04%)
     
  • 10-Yr Bond

    4.6480
    +0.0500 (+1.09%)
     
  • NASDAQ

    15,782.97
    +86.33 (+0.55%)
     
  • VOLATILITY

    15.78
    +0.09 (+0.57%)
     
  • FTSE

    8,057.66
    +12.85 (+0.16%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6818
    -0.0018 (-0.26%)
     

Assessing AbbVie’s 2018 Revenue Projections

Assessing AbbVie’s 2018 Revenue Projections

On its third-quarter earnings conference call, AbbVie (ABBV) raised its net revenue guidance for 2018 from its previous projection of $32.5 billion to $32.7 billion. The company also raised its forecast for YoY (year-over-year) operational revenue growth in 2018 from 14.5% to 15.0%. As per AbbVie’s third-quarter earnings conference call, the company expects a favorable revenue impact of less than 1% due to foreign currency fluctuations in 2018.